|Mr. Daniel S. Goldberger||CEO & Director||810.67k||N/A||1959|
|Mr. Joseph P. Errico||Co-Founder, Principal Investor & Director||64.5k||N/A||1969|
|Dr. Thomas J. Errico M.D.||Founder, Independent Director & Principal Investor||52.5k||N/A||1952|
|Mr. Brian M. Posner||CFO & Corp. Sec.||534.28k||N/A||1962|
|Mr. Michael Romaniw||Exec. VP of Systems & Operations||N/A||N/A||1957|
|Ms. Jackie Dorsky||VP of Marketing||N/A||N/A||N/A|
|Mr. Iain Strickland Ph.D.||Sr. VP of Global Sales & Strategy||N/A||N/A||N/A|
|Ms. Carrie Kochek||Sr. Director of HR||N/A||N/A||N/A|
|Dr. Peter S. Staats M.B.A., M.D.||Chief Medical Officer||N/A||N/A||1963|
|Mr. Eric J. Liebler||Sr. VP of Neurology||N/A||N/A||1964|
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
electroCore, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.